Helmsley’s Type 1 Diabetes Program: Future Technologies Initiative (LOI)

Aim: to incubate proof-of-concept, early-stage research and development in the following two tracks:

(1) Novel insulin and glucagon delivery technologies

(2) Novel sensing technologies

High-risk, high-impact, projects that have long-term vision to significantly improve glucose control while reducing the burden of living with type 1 diabetes.

Funding: up to $750K for maximum 2 years.

http://helmsleytrust.org/future-technologies-initiative